Sapience Therapeutics' Series A Round

Sapience Therapeutics raised a round of funding on July 12, 2016.

Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. The company's drug develo…

Articles about Sapience Therapeutics' Series A Round: